Unlock Long-Term Growth with 1 Thriving Stock and 2 Caution Flags Ahead

The stocks discussed in this article are all trading near their 52-week highs, which can be an indication of positive developments such as new product launches, favorable industry trends, or improved financial performance. However, not every company with momentum is a long-term winner, and many investors have lost money betting on short-term fads.

Red Rock Resorts (RRR) Falls Short

Red Rock Resorts (NASDAQ:RRR), founded in 1976, operates a range of casino resorts and entertainment properties primarily in the Las Vegas metropolitan area. While RRR has a long history of success, several factors raise concerns about its ability to continue growing at a satisfactory rate.

• Annual revenue growth over the last five years was slower than its consumer discretionary peers, with an average annual revenue growth rate of 7.1%.
• Estimated sales growth for the next 12 months implies demand will slow from its two-year trend.
• Diminishing returns on capital suggest that its earlier profit pools are drying up, indicating a lack of significant new opportunities to drive growth.

Red Rock Resorts is currently trading at $59.98 per share, which translates to a forward price-to-earnings (P/E) ratio of 35.9x. While some investors may see this as a good opportunity to buy into the stock’s momentum, it is essential to carefully evaluate RRR’s long-term prospects before making any investment decisions.

Investors considering Red Rock Resorts for their portfolio should see our free research report to learn more about its strengths and weaknesses.

Somnigroup (SGI) Lacks Excitement

Established through the merger of Tempur-Pedic and Sealy in 2012, Somnigroup (NYSE:SGI) is a bedding manufacturer renowned for its innovative memory foam mattresses and sleep products. However, despite its market position, SGI’s performance has been mixed over the past few years.

• Annual revenue growth over the last two years shows that demand lagged behind its consumer discretionary peers, averaging an annual revenue growth rate of 10.1%.
• Its ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by a weak free cash flow margin of 9.6% for the last two years.
• Eroding returns on capital suggest that its historical profit centers are aging, indicating a lack of new opportunities for growth.

Somnigroup is currently trading at $82.06 per share, which translates to a forward P/E ratio of 29.5x. Investors should exercise caution and carefully evaluate SGI’s performance before making any investment decisions.

Those looking to learn more about why Somnigroup doesn’t meet our criteria can check out our free in-depth research report.

Cencora (COR) Exceeds Expectations

Formerly known as AmerisourceBergen until its 2023 rebranding, Cencora (NYSE:COR) is a global pharmaceutical distribution company that connects manufacturers with healthcare providers, offering various services such as logistics, data analytics, and consulting.

Cencora’s impressive performance has earned it the distinction of being one of our top picks. Some key takeaways from its financials include:

• Its enormous revenue base of $316.7 billion gives it significant leverage over plan holders and advantageous reimbursement terms with healthcare providers.
• Share repurchases have amplified shareholder returns as its annual earnings per share growth of 15.2% exceeded its revenue gains over the last five years.
• Industry-leading 57.1% return on capital demonstrates management’s skill in identifying high-return investments.

Cencora is currently trading at $298.07, which translates to a valuation ratio of 17.6x forward P/E. This presents an attractive opportunity for investors looking to buy into the stock’s momentum.

Those interested in learning more about Cencora and whether now is the right time to invest can check out our full research report, available for free.

High-Quality Stocks for All Market Conditions

Investors who were caught off guard by Trump’s April 2025 tariff bombshell may have experienced a tough recovery. However, many of those stocks have since staged an impressive rebound, leaving those who panic sold on the sidelines.

Our curated list of high-quality stocks, available through StockStory, highlights companies that have generated significant returns over the last five years, with some reaching as high as 183% (as of March 31st 2025). For instance:

• Stocks like Nvidia have made our list in previous years and have seen impressive growth, with a 1,545% increase between 2020 and 2025.
• Under-the-radar businesses like Kadant, which started as a micro-cap company but has since seen its stock price rise by 351%.

To find your next big winner, check out our high-quality stocks list for free.

If you’re interested in making the most of this market rebound and identifying the top performers that will lead it forward, you can see the open role at StockStory here.